Works matching AU Rudick, Richard A.

Results: 81

Sensitive competitive-binding ELISAs for quantifying free kappa and lambda light chains in cerebrospinal fluid.

Published in:

1991

By:

Stanescu, Gabriel L.;
Swick, Alan R.;
Tuohy, Vincent K.;
Rudick, Richard A.;
Stanescu, G L;
Swick, A R;
Tuohy, V K;
Rudick, R A

Publication type:

journal article

The Future of Research in Multiple Sclerosis.

Published in:

JAMA Neurology, 2015, v. 72, n. 8, p. 853, doi. 10.1001/jamaneurol.2015.0270

By:

Fox, Robert J.;
Rudick, Richard A.

Publication type:

Article

The Clinical Meaning of Walking Speed as Measured by the Timed 25-Foot Walk in Patients With Multiple Sclerosis.

Published in:

JAMA Neurology, 2014, v. 71, n. 11, p. 1386, doi. 10.1001/jamaneurol.2014.1895

By:

Cohen, Jeffrey A.;
Krishnan, Arun V.;
Goodman, Andrew D.;
Potts, James;
Ping Wang;
Havrdova, Eva;
Polman, Chris;
Rudick, Richard A.

Publication type:

Article

Reliability of Classifying Multiple Sclerosis Disease Activity Using Magnetic Resonance Imaging in a Multiple Sclerosis Clinic.

Published in:

JAMA Neurology, 2013, v. 70, n. 3, p. 338, doi. 10.1001/2013.jamaneurol.211

By:

Altay, Ebru Erbayat;
Fisher, Elizabeth;
Jones, Stephen E.;
Hara-Cleaver, Claire;
Jar-Chi Lee;
Rudick, Richard A.

Publication type:

Article

Multiple Sclerosis Performance Test: Technical Development and Usability.

Published in:

2019

By:

Rhodes, Jane K.;
Schindler, David;
Rao, Stephen M.;
Venegas, Fernando;
Bruzik, Efrosini T.;
Gabel, Wendy;
Williams, James R.;
Phillips, Glenn A.;
Mullen, Colleen C.;
Freiburger, Jaime L.;
Mourany, Lyla;
Reece, Christine;
Miller, Deborah M.;
Bethoux, Francois;
Bermel, Robert A.;
Krupp, Lauren B.;
Mowry, Ellen M.;
Alberts, Jay;
Rudick, Richard A.

Publication type:

journal article

Predictors of long-term outcome in multiple sclerosis patients treated with interferon beta.

Published in:

Annals of Neurology, 2013, v. 73, n. 1, p. 95, doi. 10.1002/ana.23758

By:

Bermel, Robert A.;
You, Xiaojun;
Foulds, Pamela;
Hyde, Robert;
Simon, Jack H.;
Fisher, Elizabeth;
Rudick, Richard A.

Publication type:

Article

Disease modification in multiple sclerosis: Issues with relevance to clinical trial designs in Alzheimer’s disease

Published in:

Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2006, v. 2, n. 3, p. 143, doi. 10.1016/j.jalz.2006.03.011

By:

Rudick, Richard A.

Publication type:

Article

Temporal profile of serum neurofilament light in multiple sclerosis: Implications for patient monitoring.

Published in:

Multiple Sclerosis Journal, 2021, v. 27, n. 10, p. 1497, doi. 10.1177/1352458520972573

By:

Calabresi, Peter A;
Arnold, Douglas L;
Sangurdekar, Dipen;
Singh, Carol M;
Altincatal, Arman;
de Moor, Carl;
Engle, Bob;
Goyal, Jaya;
Deykin, Aaron;
Szak, Suzanne;
Kieseier, Bernd C;
Rudick, Richard A;
Plavina, Tatiana

Publication type:

Article

Neurofilament light levels are associated with long-term outcomes in multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2020, v. 26, n. 13, p. 1691, doi. 10.1177/1352458519885613

By:

Kuhle, Jens;
Plavina, Tatiana;
Barro, Christian;
Disanto, Giulio;
Sangurdekar, Dipen;
Singh, Carol M;
de Moor, Carl;
Engle, Bob;
Kieseier, Bernd C;
Fisher, Elizabeth;
Kappos, Ludwig;
Rudick, Richard A;
Goyal, Jaya

Publication type:

Article

Symbol Digit Modalities Test: A valid clinical trial endpoint for measuring cognition in multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 13, p. 1781, doi. 10.1177/1352458518808204

By:

Strober, Lauren;
DeLuca, John;
Benedict, Ralph HB;
Jacobs, Adam;
Cohen, Jeffrey A;
Chiaravalloti, Nancy;
Hudson, Lynn D;
Rudick, Richard A;
LaRocca, Nicholas G

Publication type:

Article

The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disability.

Published in:

Multiple Sclerosis Journal, 2018, v. 24, n. 11, p. 1469, doi. 10.1177/1352458517723718

By:

LaRocca, Nicholas G.;
Hudson, Lynn D.;
Rudick, Richard;
Amtmann, Dagmar;
Balcer, Laura;
Benedict, Ralph;
Bermel, Robert;
Chang, Ih;
Chiaravalloti, Nancy D.;
Chin, Peter;
Cohen, Jeffrey A.;
Cutter, Gary R.;
Davis, Mat D.;
DeLuca, John;
Feys, Peter;
Francis, Gordon;
Goldman, Myla D.;
Hartley, Emily;
Kapoor, Raj;
Lublin, Fred

Publication type:

Article

The Nine-Hole Peg Test as a manual dexterity performance measure for multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2017, v. 23, n. 5, p. 711, doi. 10.1177/1352458517690824

By:

Feys, Peter;
Lamers, Ilse;
Francis, Gordon;
Benedict, Ralph;
Phillips, Glenn;
LaRocca, Nicholas;
Hudson, Lynn D.;
Rudick, Richard

Publication type:

Article

Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2017, v. 23, n. 5, p. 704, doi. 10.1177/1352458517690823

By:

Motl, Robert W.;
Cohen, Jeffrey A.;
Benedict, Ralph;
Phillips, Glenn;
LaRocca, Nicholas;
Hudson, Lynn D.;
Rudick, Richard

Publication type:

Article

Validity of low-contrast letter acuity as a visual performance outcome measure for multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2017, v. 23, n. 5, p. 734, doi. 10.1177/1352458517690822

By:

Balcer, Laura J.;
Raynowska, Jenelle;
Nolan, Rachel;
Galetta, Steven L.;
Kapoor, Raju;
Benedict, Ralph;
Phillips, Glenn;
LaRocca, Nicholas;
Hudson, Lynn;
Rudick, Richard

Publication type:

Article

Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2017, v. 23, n. 5, p. 721, doi. 10.1177/1352458517690821

By:

Benedict, Ralph H. B.;
DeLuca, John;
Phillips, Glenn;
LaRocca, Nicholas;
Hudson, Lynn D.;
Rudick, Richard

Publication type:

Article

Factors associated with clinically significant increased walking time in multiple sclerosis: Results of a survival analysis of short-term follow-up data from a clinical database.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 4, p. 457, doi. 10.1177/1352458514544536

By:

Miller, Deborah M;
Thompson, Nicolas R;
Cohen, Jeffrey A;
Fox, Robert J;
Hartman, Jen;
Schwetz, Kathleen;
Conway, Devon S;
Rudick, Richard A

Publication type:

Article

Multiple Sclerosis Outcome Assessments Consortium: Genesis and initial project plan.

Published in:

Multiple Sclerosis Journal, 2014, v. 20, n. 1, p. 12, doi. 10.1177/1352458513503392

By:

Rudick, Richard A;
LaRocca, Nicholas;
Hudson, Lynn D

Publication type:

Article

Preventing brain atrophy should be the gold standard of effective therapy in MS (after the first year of treatment): Yes.

Published in:

Multiple Sclerosis Journal, 2013, v. 19, n. 8, p. 1003, doi. 10.1177/1352458513482385

By:

Rudick, Richard A;
Fisher, Elizabeth

Publication type:

Article

Diagnostic criteria in multiple sclerosis: Headed in the right direction but still a ways to go.

Published in:

Annals of Neurology, 2011, v. 69, n. 2, p. 234, doi. 10.1002/ana.22388

By:

Rudick, Richard A.

Publication type:

Article

Reply.

Published in:

Annals of Neurology, 2011, v. 69, n. 1, p. 216, doi. 10.1002/ana.22309

By:

Rudick, Richard A.

Publication type:

Article

Assessment of JC virus DNA in blood and urine from natalizumab-treated patients.

Published in:

Annals of Neurology, 2010, v. 68, n. 3, p. 304, doi. 10.1002/ana.22107

By:

Rudick, Richard A.;
O'Connor, Paul W.;
Polman, Chris H.;
Goodman, Andrew D.;
Ray, Soma S.;
Griffith, Nancy M.;
Jurgensen, Stephanie A.;
Gorelik, Leonid;
Forrestal, Fiona;
Sandrock, Alfred W.;
E. Goelz, Susan

Publication type:

Article

Gray matter atrophy in multiple sclerosis: A longitudinal study.

Published in:

Annals of Neurology, 2008, v. 64, n. 3, p. 255, doi. 10.1002/ana.21436

By:

Fisher, Elizabeth;
Lee, Jar-Chi;
Nakamura, Kunio;
Rudick, Richard A.

Publication type:

Article

Imaging correlates of decreased axonal Na+/K+ ATPase in chronic multiple sclerosis lesions.

Published in:

2008

By:

Young EA;
Fowler CD;
Kidd GJ;
Chang A;
Rudick R;
Fisher E;
Trapp BD;
Young, Elizabeth A;
Fowler, Christie D;
Kidd, Grahame J;
Chang, Ansi;
Rudick, Richard;
Fisher, Elizabeth;
Trapp, Bruce D

Publication type:

journal article

Imaging correlates of decreased axonal Na<sup>+</sup>/K<sup>+</sup> ATPase in chronic multiple sclerosis lesions.

Published in:

Annals of Neurology, 2008, v. 63, n. 4, p. 428, doi. 10.1002/ana.21381

By:

Young, Elizabeth A.;
Fowler, Christie D.;
Kidd, Grahame J.;
Chang, Ansi;
Rudick, Richard;
Fisher, Elizabeth;
Trapp, Bruce D.

Publication type:

Article

Health-related quality of life in multiple sclerosis: effects of natalizumab.

Published in:

Annals of Neurology, 2007, v. 62, n. 4, p. 335, doi. 10.1002/ana.21163

By:

Rudick, Richard A.;
Miller, Deborah;
Hass, Steve;
Hutchinson, Michael;
Calabresi, Peter A.;
Confavreux, Christian;
Galetta, Steven L.;
Giovannoni, Gavin;
Havrdova, Eva;
Kappos, Ludwig;
Lublin, Fred D.;
Miller, David H.;
O'Connor, Paul W.;
Phillips, J. Theodore;
Polman, Chris H.;
Radue, Ernst-Wilhelm;
Stuart, William H.;
Wajgt, Andrzej;
Weinstock-Guttman, Bianca;
Wynn, Daniel R.

Publication type:

Article

Imaging correlates of axonal swelling in chronic multiple sclerosis brains.

Published in:

Annals of Neurology, 2007, v. 62, n. 3, p. 219, doi. 10.1002/ana.21113

By:

Fisher, Elizabeth;
Chang, Ansi;
Fox, Robert J.;
Tkach, Jean A.;
Svarovsky, Therese;
Nakamura, Kunio;
Rudick, Richard A.;
Trapp, Bruce D.

Publication type:

Article

Interferon‐β for multiple sclerosis: Long‐term benefits?

Published in:

Annals of Neurology, 2007, v. 61, n. 4, p. 283, doi. 10.1002/ana.21119

By:

Richard A. Rudick;
Gary Cutter

Publication type:

Article

Significance of T2 lesions in multiple sclerosis: A 13‐year longitudinal study.

Published in:

Annals of Neurology, 2006, v. 60, n. 2, p. 236

By:

Richard A. Rudick;
Jar‐Chi Lee;
Jack Simon;
Elizabeth Fisher

Publication type:

Article

Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients.

Published in:

Annals of Neurology, 2006, v. 59, n. 3, p. 478

By:

Ranjan Dutta;
Jennifer McDonough;
Xinghua Yin;
John Peterson;
Ansi Chang;
Thalia Torres;
Tatyana Gudz;
Wendy B. Macklin;
David A. Lewis;
Robert J. Fox;
Richard Rudick;
Karoly Mirnics;
Bruce D. Trapp

Publication type:

Article

Primary progressive multiple sclerosis as a phenotype of a PLP1 gene mutation.

Published in:

Annals of Neurology, 2005, v. 58, n. 3, p. 470

By:

Ilka Warshawsky;
Richard A. Rudick;
Susan M. Staugaitis;
Marvin R. Natowicz

Publication type:

Article

Defining interferon β response status in multiple sclerosis patients.

Published in:

Annals of Neurology, 2004, v. 56, n. 4, p. 548, doi. 10.1002/ana.20224

By:

Richard A. Rudick;
Jar‐Chi Lee;
Jack Simon;
Richard M. Ransohoff;
Elizabeth Fisher

Publication type:

Article

Neuropsychological effects of interferon β-1a in relapsing multiple sclerosis.

Published in:

Annals of Neurology, 2000, v. 48, n. 6, p. 885, doi. 10.1002/1531-8249(200012)48:6<885::AID-ANA9>3.0.CO;2-1

By:

Fischer, Jill S.;
Priore, Roger L.;
Jacobs, Lawrence D.;
Cookfair, Diane L.;
Rudick, Richard A.;
Herndon, Robert M.;
Richert, John R.;
Salazar, Andres M.;
Goodkin, Donald E.;
Granger, Carl V.;
Simon, Jack H.;
Grafman, Jordan H.;
Lezak, Muriel D.;
O'Reilly Hovey, Kathleen M.;
Kawczak Perkins, Katherine;
Barilla-Clark, Danielle;
Schacter, Mark;
Shucard, David W.;
Davidson, Anna L.;
Wende, Karl E.

Publication type:

Article

Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients.

Published in:

Annals of Neurology, 2000, v. 48, n. 6, p. 893, doi. 10.1002/1531-8249(200012)48:6<893::AID-ANA10>3.0.CO;2-B

By:

Bjartmar, Carl;
Kidd, Grahame;
Mörk, Sverre;
Rudick, Richard;
Trapp, Bruce D.

Publication type:

Article

Magnetic resonance studies of intramuscular interferon β-1a for relapsing multiple sclerosis.

Published in:

Annals of Neurology, 1998, v. 43, n. 1, p. 79, doi. 10.1002/ana.410430114

By:

Simon, Jack H.;
Jacobs, Lawrence D.;
Campion, Marilyn;
Wende, Karl;
Simonian, Nancy;
Cookfair, Diane L.;
Rudick, Richard A.;
Herndon, Robert M.;
Richert, John R.;
Salazar, Andres M.;
Alam, John J.;
Fischer, Jill S.;
Goodkin, Donald E.;
Granger, Carl V.;
Lajaunie, Michelle;
Martens-Davidson, Anna L.;
Meyer, Maryjoel;
Sheeder, Jeanelle;
Choi, Kim;
Scherzinger, Ann L.

Publication type:

Article

Recommendations from the national multiple sclerosis society clinical outcomes assessment task force.

Published in:

Annals of Neurology, 1997, v. 42, n. 3, p. 379, doi. 10.1002/ana.410420318

By:

Rudick, Richard;
Antel, Jack;
Confavreux, Christian;
Cutter, Gary;
Ellison, George;
Fischer, Jill;
Lublin, Fred;
Miller, Aaron;
Petkau, John;
Rao, Stephen;
Reingold, Stephen;
Syndulko, Karl;
Thompson, Alan;
Wallenberg, Joy;
Weinshenker, Brian;
Willoughby, Ernest

Publication type:

Article

Interferon beta induces interleukin-10 expression: Relevance to multiple sclerosis.

Published in:

Annals of Neurology, 1996, v. 40, n. 4, p. 618, doi. 10.1002/ana.410400412

By:

Rudick, Richard A.;
Ransohoff, Richard M.;
Peppler, Richard;
Medendorp, Sharon Vanderbrug;
Lehmann, Paul;
Alam, John

Publication type:

Article

Clinical outcomes assessment in multiple sclerosis.

Published in:

Annals of Neurology, 1996, v. 40, n. 3, p. 469, doi. 10.1002/ana.410400321

By:

Rudick, Richard;
Fischer, Jill;
Antel, Jack;
Confavreux, Christian;
Cutter, Gary;
Ellison, George;
Lublin, Fred;
Miller, Aaron;
Petkau, John;
Rao, Stephen;
Reingold, Stephen;
Syndulko, Karl;
Thompson, Alan;
Wallenberg, Joy;
Weinshenker, Brain;
Willoughby, Ernest

Publication type:

Article

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis.

Published in:

Annals of Neurology, 1996, v. 39, n. 3, p. 285, doi. 10.1002/ana.410390304

By:

Jacobs, Lawrence D.;
Cookfair, Diane L.;
Rudick, Richard A.;
Herndon, Robert M.;
Richert, John R.;
Salazar, Andres M.;
Fischer, Jill S.;
Goodkin, Donald E.;
Granger, Carl V.;
Simon, Jack H.;
Alam, John J.;
Bartoszak, David M.;
Bourdette, Dennis N.;
Braiman, Jonathan;
Brownscheidle, Carol M.;
Coats, Michael E.;
Cohan, Stanley L.;
Dougherty, David S.;
Kinkel, Revere P.;
Mass, Michele K.

Publication type:

Article

The interferons: Biological effects, mechanisms of action, and use in multiple sclerosis.

Published in:

Annals of Neurology, 1995, v. 37, n. 1, p. 7, doi. 10.1002/ana.410370105

By:

Weinstock-Guttman, Bianca;
Ransohoff, Richard M.;
Kinkel, R. Philip;
Rudick, Richard A.

Publication type:

Article

Low-dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis.

Published in:

Annals of Neurology, 1995, v. 37, n. 1, p. 30, doi. 10.1002/ana.410370108

By:

Goodkin, Donald E.;
Rudick, Richard A.;
Medendorp, Sharon Vanderbrug;
Daughtry, Michele M.;
Schwetz, Kathleen M.;
Fischer, Jill;
van Dyke, Carolyn

Publication type:

Article

The cerebrospinal fluid Edited by Robert M. Herndon, MD. and Roger A. Brumdack, MD Antwerp, Kluwer Acadmic, 1989 306 pp, Illustrated, $110.00.

Published in:

Annals of Neurology, 1991, v. 29, n. 1, p. 113, doi. 10.1002/ana.410290127

By:

Rudick, Richard A.

Publication type:

Article

A Radical Proposal: Integrate Clinical Investigation into the U.S. Health Care System.

Published in:

Science Translational Medicine, 2009, v. 1, n. 4, p. 1, doi. 10.1126/scitranslmed.3000296

By:

Rudick, Richard A.;
Cosgrove, Delos M.

Publication type:

Article

Long-Term Magnetization Transfer Ratio Evolution in Multiple Sclerosis White Matter Lesions.

Published in:

2018

By:

Yufan Zheng;
Jar-Chi Lee;
Rudick, Richard;
Fisher, Elizabeth;
Zheng, Yufan;
Lee, Jar-Chi

Publication type:

journal article

Health-Related Quality of Life in Multiple Sclerosis: Current Evidence, Measurement and Effects of Disease Severity and Treatment.

Published in:

CNS Drugs, 2008, v. 22, n. 10, p. 827, doi. 10.2165/00023210-200822100-00004

By:

Rudick, Richard A;
Miller, Deborah M

Publication type:

Article

A 29-year-old man with multiple sclerosis.

Published in:

1998

By:

Rudick, Richard A.;
Rudick, R A

Publication type:

journal article

Development of a multiple sclerosis functional composite as a clinical trial outcome measure.

Published in:

Brain: A Journal of Neurology, 1999, v. 122, n. 5, p. 871, doi. 10.1093/brain/122.5.871

By:

Cutter, Gary R.;
Baier, Monika L.;
Rudick, Richard A.;
Cookfair, Diane L.;
Fischer, Jill S.;
Petkau, John;
Syndulko, Karl;
Weinshenker, Brian G.;
Antel, Jack P.;
Confavreux, Christian;
Ellison, George W.;
Lublin, Fred;
Miller, Aaron E.;
Rao, Stephen M.;
Reingold, Stephen;
Thompson, Alan;
Willoughby, Ernest

Publication type:

Article

The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL.

Published in:

2009

By:

Hutchinson, Michael;
Kappos, Ludwig;
Calabresi, Peter;
Confavreux, Christian;
Giovannoni, Gavin;
Galetta, Steven;
Havrdova, Eva;
Lublin, Fred;
Miller, David;
O’Connor, Paul;
Phillips, J.;
Polman, Chris;
Radue, Ernst-Wilhelm;
Rudick, Richard;
Stuart, William;
Wajgt, Andrzej;
Weinstock-Guttman, Bianca;
Wynn, Daniel;
Lynn, Frances;
Panzara, Michael

Publication type:

Correction Notice

The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL.

Published in:

Journal of Neurology, 2009, v. 256, n. 3, p. 405, doi. 10.1007/s00415-009-0093-1

By:

Hutchinson, Michael;
Kappos, Ludwig;
Calabresi, Peter A.;
Confavreux, Christian;
Giovannoni, Gavin;
Galetta, Steven L.;
Havrdova, Eva;
Lublin, Fred D.;
Miller, David H.;
O'Connor, Paul W.;
Phillips, J. Theodore;
Polman, Chris H.;
Radue, Ernst-Wilhelm;
Rudick, Richard A.;
Stuart, William H.;
Wajgt, Andrzej;
Weinstock-Guttman, Bianca;
Wynn, Daniel R.;
Lynn, Frances;
Panzara, Michael A.

Publication type:

Article

Real-world effectiveness of dimethyl fumarate versus fingolimod in a cohort of patients with multiple sclerosis using standardized, quantitative outcome metrics.

Published in:

Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2022, p. 1, doi. 10.1177/20552173211069852

By:

Hersh, Carrie M;
Altincatal, Arman;
Belviso, Nicholas;
Kapadia, Shivani;
de Moor, Carl;
Rudick, Richard;
Williams, James Rhys;
Miller, Catherine;
Koulinska, Irene

Publication type:

Article

Impact of natalizumab on quality of life in a real-world cohort of patients with multiple sclerosis: Results from MS PATHS.

Published in:

Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2021, p. 1, doi. 10.1177/20552173211004634

By:

Hersh, Carrie M;
Kieseier, Bernd;
Moor, Carl de;
Miller, Deborah M;
Campagnolo, Denise;
Williams, James R;
Fitzgerald, Kathryn C;
Xiong, Kuangnan;
McGinley, Marisa P;
Hyland, Megan;
Rudick, Richard A;
Ziemssen, Tjalf;
Koulinska, Irene

Publication type:

Article